Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Rangering i aksjer #3557
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Aksjekurs
$3.28
Sist synkronisert: 2026-07-31
Markedsverdi
$5.10B
Endring (1 dag)
0.00%
Endring (1 år)
-49.70%
Land
TW
Handel Caliway Biopharmaceuticals Co. L (6919)

Kategori

Aksjeprishistorikk for Caliway Biopharmaceuticals Co. L (6919)
Høyeste sluttskurs: $3.30 den 2026-07-01

Laveste sluttskurs: $0.20 den 2022-12-01
Aksjeprishistorikk for Caliway Biopharmaceuticals Co. L fra 2022 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -13.85%
2025 190.26%
2024 181.33%
2023 210.73%
2022 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$768.37 6.79%
CH